Digital Health Apps Only Help Normal Weight Diabetics Reduce Heart Disease Risk

Digital health interventions show promise for reducing cardiovascular disease risk in people with type 2 diabetes, but their effectiveness depends heavily on body weight. This finding has significant implications for the millions of diabetics who rely on health apps and digital tools to manage their condition.

Researchers conducted a secondary analysis of the SMARTDiabetes trial, examining 2,072 patients with type 2 diabetes over 24 months. Participants were divided into normal weight (714 people), overweight (996 people), and obese (362 people) groups based on their baseline BMI.

The results revealed striking differences in how digital health interventions affected cardiovascular risk across weight categories. Normal-weight participants experienced a significant 1.1% reduction in their 10-year cardiovascular disease risk when using digital health tools compared to usual care. However, overweight and obese participants saw no meaningful cardiovascular benefits from the same interventions.

This disparity suggests that current digital health approaches may not adequately address the complex metabolic and physiological challenges faced by people carrying excess weight. Since obesity is a major risk factor for both diabetes and cardiovascular disease, this population arguably needs the most effective interventions.

The findings highlight a critical gap in personalized digital health solutions. As digital therapeutics become increasingly common in diabetes management, developers and healthcare providers must create tailored approaches that account for individual body weight and metabolic profiles. The study suggests that one-size-fits-all digital interventions may inadvertently widen health disparities rather than closing them, particularly disadvantaging those at highest cardiovascular risk.